Hexagon Nutrition Peer Comparison

NSE: HEXAGON | BSE: 544785

₹68.37

₹-0.79 (-1.14%)

As on 28-Aug-2026IST

Market cap

₹841 Cr

Revenue (TTM)

₹325 Cr

P/E Ratio

22.2

P/B Ratio

3.5

Div. Yield

0 %

Edit

	Hexagon Nutrition	Mukka Proteins	Dindigul Farm Product	Sai Life Sciences	Marksans Pharma
Market cap (₹ Cr)	841	753	34	31,434	14,932
Revenue (₹ Cr)	325	1,768	62	2,250	3,172
Net Profit (₹ Cr)	24.38	72.56	-5.61	361.74	521.27
Net Margin (%)	7.36	4.04	-8.93	15.77	15.92
RoE (%)	14.11	14.65	-24.65	15.47	18.10
Price to Earnings	22.18	10.89	9.19	86.90	28.90
Price-To-Book	3.47	1.45	0.97	12.31	4.70

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement (₹ Cr)

	Hexagon Nutrition	Mukka Proteins	Dindigul Farm Product	Sai Life Sciences	Marksans Pharma
Operating Revenue	324.93	1,006.42	62.05	1,694.57	2,622.85
Total Income	331.29	1,021.53	62.83	1,731.35	2,689.17
Total Expenditure	284.06	911.53	62.55	1,286.73	2,090.16
EBITDA	40.87	94.88	-0.51	407.84	532.68
Depreciation	8.77	13.55	1.87	138.57	83.39
EBIT	32.10	81.33	-2.37	269.27	449.30
Interest	3.95	37.25	2.89	78.34	11.66
Other Income	6.36	15.12	0.78	36.78	66.33
Exceptional Items	-0.80	--	--	--	--
Profit before Tax	33.72	60.27	-4.48	227.70	503.97
Provision for Tax	9.34	12.17	1.13	57.57	121.35
Profit after Tax	24.38	48.10	-5.61	170.13	382.62

Liabilities (₹ Cr)

	Hexagon Nutrition	Mukka Proteins	Dindigul Farm Product	Sai Life Sciences	Marksans Pharma
Shareholder's Funds	194.18	440.70	35.21	2,128.35	2,466.91
Minority Interest	--	15.80	--	--	22.47
Non-Current Liabilities	11.72	9.41	15.80	321.62	272.91
Current Liabilities	52.66	610.41	13.32	759.14	477.34
Total Liabilities	261.36	1,076.32	64.56	3,209.12	3,239.63

Assets (₹ Cr)

	Hexagon Nutrition	Mukka Proteins	Dindigul Farm Product	Sai Life Sciences	Marksans Pharma
Non-Current Assets	74.93	150.60	22.53	1,677.96	1,035.51
Current Assets	183.64	925.72	41.81	1,531.16	2,204.12
Total Assets	261.36	1,076.32	64.56	3,209.12	3,239.63
Total Debt*	26.60	450.29	17.92	128.64	23.09
Net Current Assets	130.98	315.32	28.49	772.02	1,726.78
Contingent Liabilities	86.98	116.73	--	58.11	--

Cashflow (₹ Cr)

	Hexagon Nutrition	Mukka Proteins	Dindigul Farm Product	Sai Life Sciences	Marksans Pharma
Cash From Operating Activities	37.79	-111.93	-12.43	314.05	206.66
Cash Flow from Investing Activities	-22.69	-34.99	-11.19	-536.67	-49.01
Cash from Financing Activities	-19.24	55.55	23.61	301.43	-65.15
Net Cash Inflow / Outflow	-4.13	-91.36	0.00	78.81	92.51

Ratios

Profitability Ratios

	Hexagon Nutrition	Mukka Proteins	Dindigul Farm Product	Sai Life Sciences	Marksans Pharma
ROCE (%)	17.37	11.82	-3.86	15.53	22.50
ROE (%)	14.11	11.50	-24.65	11.02	16.89
ROA (%)	9.62	4.77	-9.59	6.17	12.93
EBIT Margin (%)	14.53	10.93	0.45	26.24	22.84
Net Margin (%)	7.36	4.71	-8.93	9.83	14.23
Cash Profit Margin (%)	10.20	6.01	-6.04	18.20	16.97

Growth Ratios

	Hexagon Nutrition	Mukka Proteins	Dindigul Farm Product	Sai Life Sciences	Marksans Pharma
Revenue Growth (%)	9.14	-27.06	-27.46	15.66	20.46
EBIT Growth (%)	50.38	-10.30	-97.87	40.60	17.68
Net Profit Growth (%)	99.58	-35.27	-164.22	105.45	21.51
EPS Growth (%)	99.59	-33.68	-147.27	74.12	21.32
Book Value Growth (%)	11.19	11.26	240.67	120.22	19.46

Valuation Ratios

	Hexagon Nutrition	Mukka Proteins	Dindigul Farm Product	Sai Life Sciences	Marksans Pharma
Price / Earnings	0.00	21.12	0.00	93.36	26.48
Price / Book Value	0.00	2.23	1.64	7.48	4.08
Dividend Yield (%)	--	0.00	0.00	0.00	0.36
EV/EBITDA	0.63	12.63	274.16	34.97	15.68
Market Cap (₹ Cr)	0.00	980.95	57.83	15,882.87	10,075.92

Solvency Ratios

	Hexagon Nutrition	Mukka Proteins	Dindigul Farm Product	Sai Life Sciences	Marksans Pharma
Debt to Equity	0.14	1.02	0.51	0.06	0.01
Short term debt to equity ratio	0.08	1.01	0.04	0.06	0.01
Current Ratio	3.49	1.52	3.14	2.02	4.62
Quick Ratio	2.32	0.59	2.56	1.86	2.85
Interest Coverage	9.54	2.62	-0.55	3.91	44.22

Operating Efficiency Ratios

	Hexagon Nutrition	Mukka Proteins	Dindigul Farm Product	Sai Life Sciences	Marksans Pharma
Debtors to sales (%)	18.41	19.85	6.18	20.94	20.59
Asset Turnover	1.28	1.02	1.06	0.61	0.93
Receivable days	60.85	68.51	18.94	65.73	65.99
Inventory Days	78.96	175.65	65.45	22.19	97.24
Payable days	38.92	65.49	132.39	180.62	91.59
Cash Conversion Cycle	100.89	178.67	-47.99	-92.70	71.65